“We are honored to have earned a place among some of the best life sciences companies in our region as one of the Tech50 finalists,” said John Marous, TandemLife CEO & Chairman of the Board. “In 2012, our team committed to deliver on an extremely aggressive program; developing and launching six medical devices in four years. In our 20th year we’ve realized that goal by commercializing our TandemLung oxygenator and rebranding ourselves to TandemLife Company, being named a Tech50 finalist is a true testament to our team’s dedication to advancing care for critically ill heart and respiratory failure patients.”
Since releasing their latest innovation, TandemLung, in March of this year, TandemLife has rebranded with a focus on providing medical devices that deliver on the mission of “Life Support Simplified”. TandemLife’s classic TandemHeart platform has helped thousands of heart failure patients worldwide. With the addition of their newest product lines, ProtekDuo, TandemLung, and TandemLife, the TandemLife platform is now the most comprehensive cardiopulmonary bypass system on the market. TandemLife has several more innovations due for commercial release in 2016.
About Tech 50
For the past 20 years, the Pittsburgh Technology Council has awarded the most innovative and successful Southwestern Pennsylvania companies with the prestigious Tech50 Award. This annual award celebrates the accomplishments of leading edge companies in health IT, life sciences, manufacturing, consumer products, consulting services, and other innovative technologies. For more information about the Pittsburgh technology council, visit http://www.pghtech.org/, and to learn more about the Tech 50 Awards, visit http://www.pghtech.org/events/tech-50.aspx#About.